Human papillomavirus testing and reporting rates in 2012: Results of a College of American Pathologists national survey

Archives of Pathology and Laboratory Medicine

Volumn 139, Issue 6, 2015, Pages 757-761

  Zhao, Chengquan ^a   Moriarty, Ann T ^b   Ghofrani, Mohiedean ^c   Husain, Mujtaba ^d   Tambouret, Rosemary H ^e   Laucirica, Rodolfo ^f   Laser, Alice ^g   Fischer, Andrew ^h   Ocal, Idris T ⁱ   Souers, Rhona J ^j   Russell, Donna K ^k   Fan, Fang ^l   Crothers, Barbara A ^m  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Ameripath Inc   (United States)

^c Peace Health Medical Group   (United States)

^d UNIVERSITY OF CENTRAL FLORIDA   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g Northwell Health   (United States)

^h UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

ⁱ MAYO CLINIC   (United States)

^j North Carolina   (United States)

^k UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^l UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^m WALTER REED ARMY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; DIAGNOSTIC PROCEDURE; FEMALE; GENETICS; GENOTYPE; GOOD LABORATORY PRACTICE; HEALTH CARE ORGANIZATION; HOST PATHOGEN INTERACTION; HUMAN; INFORMATION PROCESSING; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PHYSIOLOGY; PROCEDURES; QUESTIONNAIRE; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX; STANDARDS; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CLINICAL LABORATORY TECHNIQUES; DATA COLLECTION; FEMALE; GENOTYPE; HOST-PATHOGEN INTERACTIONS; HUMANS; LABORATORY PROFICIENCY TESTING; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY, CLINICAL; QUESTIONNAIRES; SOCIETIES, SCIENTIFIC; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 84930412024     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2014-0393-CP     Document Type: Article

References (14)

1. Davey DD, Naryshkin S, Nielsen ML, Kline TS. Atypical squamous cells of undetermined significance: interlaboratory comparison and quality assurance monitors. Diagn Cytopathol. 1994;11(4):390-396.
2. Davey DD, Nielsen ML, Naryshkin S, Robb JA, Cohen T, Kline TS. Atypical squamous cells of undetermined significance: current laboratory practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 1996;120(5):440-444.
3. Davey DD, Nielsen ML, Rosenstock W, Kline TS. Terminology and specimen adequacy in cervicovaginal cytology: the College of American Pathologists Interlaboratory Comparison Program experience. Arch Pathol Lab Med. 1992;116(9):903-907.
4. Davey DD, Woodhouse S, Styer P, Stastny J, Mody D. Atypical epithelial cells and specimen adequacy: current laboratory practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 2000;124(2):203-211.
5. Davey DD, Neal MH, Wilbur DC, Colgan TJ, Styer PE, Mody DR. Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 2004;128(11):1224-1229.
6. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287(16):2120-2129.
7. Wright TC, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol. 2004;103(2):304-309.
8. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis. 2007;11(4): 201-222.
9. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis. 2012;16(3):175-204.
10. Massad LS, Einstein MH, Huh WK, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013;121(4):829-846.
11. Katki HA, Kinney WK, Fetterman B, et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol. 2011;12(7):663-672.
12. Moriarty AT, Schwartz MR, Eversole G, et al. Human papillomavirus testing and reporting rates: practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Gynecologic Cytology in 2006. Arch Pathol Lab Med. 2008;132(8):1290-1294.
13. Moriarty AT. A rock and a hard place: HPV testing and financial gain. Diagn Cytopathol. 2007;35(8):463-464.
14. Lee JW, Berkowitz Z, Saraiya M. Low-risk human papillomavirus testing and other nonrecommended human papillomavirus testing practices among US health care providers. Obstet Gynecol. 2011;118(1):4-13.